Author Correction: DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance.

Saved in:
Bibliographic Details
Title: Author Correction: DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance.
Authors: Schröder M; Novartis Institutes for BioMedical Research, Basel, Switzerland. martin-1.schroeder@novartis.com., Renatus M; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Ridgeline Discovery, Basel, Switzerland., Liang X; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Meili F; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Zoller T; Novartis Institutes for BioMedical Research, Basel, Switzerland., Ferrand S; Novartis Institutes for BioMedical Research, Basel, Switzerland., Gauter F; Novartis Institutes for BioMedical Research, Basel, Switzerland., Li X; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Sigoillot F; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Gleim S; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Stachyra TM; Novartis Institutes for BioMedical Research, Basel, Switzerland., Thomas JR; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Begue D; Novartis Institutes for BioMedical Research, Basel, Switzerland., Khoshouei M; Novartis Institutes for BioMedical Research, Basel, Switzerland., Lefeuvre P; Novartis Institutes for BioMedical Research, Basel, Switzerland., Andraos-Rey R; Novartis Institutes for BioMedical Research, Basel, Switzerland., Chung B; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Ma R; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Pinch B; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Hofmann A; Novartis Institutes for BioMedical Research, Basel, Switzerland., Schirle M; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Schmiedeberg N; Novartis Institutes for BioMedical Research, Basel, Switzerland., Imbach P; Novartis Institutes for BioMedical Research, Basel, Switzerland., Gorses D; Novartis Institutes for BioMedical Research, Basel, Switzerland., Calkins K; Novartis Institutes for BioMedical Research, Basel, Switzerland., Bauer-Probst B; Novartis Institutes for BioMedical Research, Basel, Switzerland., Maschlej M; Novartis Institutes for BioMedical Research, Basel, Switzerland., Niederst M; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Maher R; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Henault M; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Alford J; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Ahrne E; Novartis Institutes for BioMedical Research, Basel, Switzerland., Tordella L; Novartis Institutes for BioMedical Research, Basel, Switzerland., Hollingworth G; Novartis Institutes for BioMedical Research, Basel, Switzerland., Thomä NH; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.; Swiss Institute for Experimental Cancer Research (ISREC), École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland., Vulpetti A; Novartis Institutes for BioMedical Research, Basel, Switzerland., Radimerski T; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Ridgeline Discovery, Basel, Switzerland., Holzer P; Novartis Institutes for BioMedical Research, Basel, Switzerland., Carbonneau S; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Thoma CR; Novartis Institutes for BioMedical Research, Cambridge, MA, USA. cthoma@ridgelinediscovery.com.; Ridgeline Discovery, Basel, Switzerland. cthoma@ridgelinediscovery.com.
Source: Nature communications [Nat Commun] 2024 Aug 19; Vol. 15 (1), pp. 7109. Date of Electronic Publication: 2024 Aug 19.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39160182
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Schröder+M%22">Schröder M</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland. martin-1.schroeder@novartis.com.<br /><searchLink fieldCode="AU" term="%22Renatus+M%22">Renatus M</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Ridgeline Discovery, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Liang+X%22">Liang X</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Meili+F%22">Meili F</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Zoller+T%22">Zoller T</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ferrand+S%22">Ferrand S</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Gauter+F%22">Gauter F</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sigoillot+F%22">Sigoillot F</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Gleim+S%22">Gleim S</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Stachyra+TM%22">Stachyra TM</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Thomas+JR%22">Thomas JR</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Begue+D%22">Begue D</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Khoshouei+M%22">Khoshouei M</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lefeuvre+P%22">Lefeuvre P</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Andraos-Rey+R%22">Andraos-Rey R</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Chung+B%22">Chung B</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ma+R%22">Ma R</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Pinch+B%22">Pinch B</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hofmann+A%22">Hofmann A</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schirle+M%22">Schirle M</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Schmiedeberg+N%22">Schmiedeberg N</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Imbach+P%22">Imbach P</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Gorses+D%22">Gorses D</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Calkins+K%22">Calkins K</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bauer-Probst+B%22">Bauer-Probst B</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Maschlej+M%22">Maschlej M</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Niederst+M%22">Niederst M</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Maher+R%22">Maher R</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Henault+M%22">Henault M</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Alford+J%22">Alford J</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ahrne+E%22">Ahrne E</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Tordella+L%22">Tordella L</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hollingworth+G%22">Hollingworth G</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Thomä+NH%22">Thomä NH</searchLink>; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.; Swiss Institute for Experimental Cancer Research (ISREC), École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Vulpetti+A%22">Vulpetti A</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Radimerski+T%22">Radimerski T</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Ridgeline Discovery, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Holzer+P%22">Holzer P</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Carbonneau+S%22">Carbonneau S</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Thoma+CR%22">Thoma CR</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA. cthoma@ridgelinediscovery.com.; Ridgeline Discovery, Basel, Switzerland. cthoma@ridgelinediscovery.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2024 Aug 19; Vol. 15 (1), pp. 7109. <i>Date of Electronic Publication: </i>2024 Aug 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39160182
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-024-51317-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 7109
    Titles:
      – TitleFull: Author Correction: DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Schröder M
      – PersonEntity:
          Name:
            NameFull: Renatus M
      – PersonEntity:
          Name:
            NameFull: Liang X
      – PersonEntity:
          Name:
            NameFull: Meili F
      – PersonEntity:
          Name:
            NameFull: Zoller T
      – PersonEntity:
          Name:
            NameFull: Ferrand S
      – PersonEntity:
          Name:
            NameFull: Gauter F
      – PersonEntity:
          Name:
            NameFull: Li X
      – PersonEntity:
          Name:
            NameFull: Sigoillot F
      – PersonEntity:
          Name:
            NameFull: Gleim S
      – PersonEntity:
          Name:
            NameFull: Stachyra TM
      – PersonEntity:
          Name:
            NameFull: Thomas JR
      – PersonEntity:
          Name:
            NameFull: Begue D
      – PersonEntity:
          Name:
            NameFull: Khoshouei M
      – PersonEntity:
          Name:
            NameFull: Lefeuvre P
      – PersonEntity:
          Name:
            NameFull: Andraos-Rey R
      – PersonEntity:
          Name:
            NameFull: Chung B
      – PersonEntity:
          Name:
            NameFull: Ma R
      – PersonEntity:
          Name:
            NameFull: Pinch B
      – PersonEntity:
          Name:
            NameFull: Hofmann A
      – PersonEntity:
          Name:
            NameFull: Schirle M
      – PersonEntity:
          Name:
            NameFull: Schmiedeberg N
      – PersonEntity:
          Name:
            NameFull: Imbach P
      – PersonEntity:
          Name:
            NameFull: Gorses D
      – PersonEntity:
          Name:
            NameFull: Calkins K
      – PersonEntity:
          Name:
            NameFull: Bauer-Probst B
      – PersonEntity:
          Name:
            NameFull: Maschlej M
      – PersonEntity:
          Name:
            NameFull: Niederst M
      – PersonEntity:
          Name:
            NameFull: Maher R
      – PersonEntity:
          Name:
            NameFull: Henault M
      – PersonEntity:
          Name:
            NameFull: Alford J
      – PersonEntity:
          Name:
            NameFull: Ahrne E
      – PersonEntity:
          Name:
            NameFull: Tordella L
      – PersonEntity:
          Name:
            NameFull: Hollingworth G
      – PersonEntity:
          Name:
            NameFull: Thomä NH
      – PersonEntity:
          Name:
            NameFull: Vulpetti A
      – PersonEntity:
          Name:
            NameFull: Radimerski T
      – PersonEntity:
          Name:
            NameFull: Holzer P
      – PersonEntity:
          Name:
            NameFull: Carbonneau S
      – PersonEntity:
          Name:
            NameFull: Thoma CR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 08
              Text: 2024 Aug 19
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1